[Comparing effect in the management of erectile dysfunction by using 2 sets of drugs of intracavernosal injection].
OBJECTIVE
To supply clinical data for drug selextion in the treatment of erectile dysfunction through intracavernosal injection.


METHODS
Fifty-six ED patients were randomly classified into 2 groups and received phentolamine along with papaverine (for group 1) or phentolamine, papaverine and ligustrazin hydrochloride(for group 2).


RESULTS
Patients in group 2 enjoyed a longer time of erection. More patients in group 2 succeeded in having enough erection time and hardness to complete sexual intercourse (P < 0.05).


CONCLUSIONS
The extrainjection of ligustrazin hydrochloride injection can help prolong erection duration and hardness and reduce tubercles that might occur in the corpus carvernosal. Therefore it is a safe and inexpensive drug in the intracarvernous injection treatment.
Jian
Hong-Yan
HY
Medical Service Center of Family Planning of Hanzhong District, Hanzhong, Shan'xi 723000, China.
Hao
Ji-Chang
JC
D000328:Adult; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage*; D010646:Phentolamine / Q000008:administration & dosage*; D011719:Pyrazines / Q000008:administration & dosage*
D011719:Pyrazines; D010208:Papaverine; C017953:tetramethylpyrazine; D010646:Phentolamine